Use of Pharmacologic Agents for the Prevention of Osteoporosis Among Older Women with Low Bone Mass Is Discordant with National Osteoporosis Foundation Guidance

被引：0

作者：

Zhang, Jie ^{[1
]}

Curtis, Jeffery R. ^{[1
]}

Delzell, Elizabeth S. ^{[1
]}

Saag, Kenneth G. ^{[1
]}

机构：

[1] Univ Alabama, Birmingham, AL USA

来源：

ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

1121

引用

页码：S438 / S438

页数：1

共 50 条

[21] Estimates of the Proportion of Older White Men Who Would Be Recommended for Pharmacologic Treatment by the New US National Osteoporosis Foundation Guidelines
Donaldson, Meghan G.
Cawthon, Peggy M.
Lui, Lily Y.
Schousboe, John T.
Ensrud, Kristine E.
Taylor, Brent C.
Cauley, Jane A.
Hillier, Teresa A.
Dam, Thuy T.
Curtis, Jeff R.
Black, Dennis M.
Bauer, Douglas C.
Orwoll, Eric S.
Cummings, Steven R.
JOURNAL OF BONE AND MINERAL RESEARCH, 2010, 25 (07) : 1506 - 1511
[22] Asia-pacific consensus on osteoporotic fracture prevention in postmenopausal women with low bone mass or osteoporosis but no fragility fractures
Huang, Chun-Feng
Chen, Jung-Fu
Reid, Ian R.
Chan, Wing P.
Ebeling, Peter Robert
Langdahl, Bente
Tu, Shih-Te
Matsumoto, Toshio
Chan, Ding-Cheng
Chung, Yoon-Sok
Chen, Fang-Ping
Lewiecki, E. Michael
Tsai, Keh-Sung
Yang, Rong-Sen
Ang, Seng Bin
Huang, Ko-En
Chang, Yin-Fan
Chen, Chung-Hwan
Lee, Joon-Kiong
Ma, Hsin-I
Xia, Weibo
Mithal, Ambrish
Kendler, David L.
Cooper, Cyrus
Hwang, Jawl-Shan
Wu, Chih-Hsing
JOURNAL OF THE FORMOSAN MEDICAL ASSOCIATION, 2023, 122 : S14 - S20
[23] Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance
Looker, A. C.
Dawson-Hughes, B.
Tosteson, A. N. A.
Johansson, H.
Kanis, J. A.
Melton, L. J., III
OSTEOPOROSIS INTERNATIONAL, 2011, 22 (02) : 541 - 549
[24] Hip fracture risk in older US adults by treatment eligibility status based on new National Osteoporosis Foundation guidance
A. C. Looker
B. Dawson-Hughes
A. N. A. Tosteson
H. Johansson
J. A. Kanis
L. J. Melton
Osteoporosis International, 2011, 22 : 541 - 549
[25] Cortical bone mass and risk factors for osteoporosis among postmenopausal women in our environment
Sánchez, JM
Lenza, HR
Prieto, JC
Zamorano, JDP
REVISTA CLINICA ESPANOLA, 2001, 201 (01): : 16 - 20
[26] Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene
Powles, Trevor J.
Diem, Susan J.
Fabian, Carol J.
Neven, Patrick
Wickerham, D. Lawrence
Cox, David A.
Muram, David
Agnusdei, Donato
Dowsett, Sherie A.
Amewou-Atisso, Messan
Cummings, Steven R.
BREAST CANCER RESEARCH AND TREATMENT, 2012, 134 (01) : 299 - 306
[27] Postmenopausal women with minimal trauma fractures are unapprised of the existence of low bone mass or osteoporosis
Edwards, BJ
Iris, M
Ferkel, E
Feinglass, J
MATURITAS, 2006, 53 (03) : 260 - 266
[28] Systematic review of raloxifene in postmenopausal Japanese women with osteoporosis or low bone mass (osteopenia)
Fujiwara, Saeko
Hamaya, Etsuro
Sato, Masayo
Graham-Clarke, Peita
Flynn, Jennifer A.
Burge, Russel
CLINICAL INTERVENTIONS IN AGING, 2014, 9 : 1879 - 1893
[29] Breast cancer incidence in postmenopausal women with osteoporosis or low bone mass using arzoxifene
Trevor J. Powles
Susan J. Diem
Carol J. Fabian
Patrick Neven
D. Lawrence Wickerham
David A. Cox
David Muram
Donato Agnusdei
Sherie A. Dowsett
Messan Amewou-Atisso
Steven R. Cummings
Breast Cancer Research and Treatment, 2012, 134 : 299 - 306
[30] Low Bone Mass is Associated with Stroke in Chinese Postmenopausal Women: The Chongqing Osteoporosis Study
Zhou, Rui
Liu, Dong
Li, Rui
Zhou, Shiming
Cui, Min
Chen, Lin
Zhou, Huadong
CELL BIOCHEMISTRY AND BIOPHYSICS, 2015, 71 (03) : 1695 - 1701

← 1 2 3 4 5 →